Brief: Pure Biologics Signs Deal With Customer On Aptamers

Multiqure SA

03/02/2022 09:52

Feb 3 (Reuters) - Pure Biologics SA  PUR1.WA :
    * SAYS SIGNS DEAL WITH CUSTOMER WHICH GUARANTEES COMPANY
PROFIT
FROM COMMERCIALISATION OF APTAMER
    * SAYS COMPANY TO GET 0.2 MILLION ZLOTY ONE TIME PAYMENT AND
6% OF
CUSTOMERS NET PROFIT FROM SALES OF PRODUCT BASED ON COMPANY'S
APTAMER
    * SAYS CUSTOMER PLANS TO USE APTAMER FOR THERAPEUTIC
SOLUTION WITH
ANTIVIRAL POTENTIAL

Source text for Eikon:  ID:nEM5mqc6Ta 
Further company coverage:  PUR1.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))